Nhận Dạng Quốc Tế & Đặc Tính Hóa Học
Monoisotopic mass
340.189926032
InChI
InChI=1S/C19H24N4O2/c20-18(21)14-4-8-16(9-5-14)24-12-2-1-3-13-25-17-10-6-15(7-11-17)19(22)23/h4-11H,1-3,12-13H2,(H3,20,21)(H3,22,23)
InChI Key
InChIKey=XDRYMKDFEDOLFX-UHFFFAOYSA-N
IUPAC Name
4-{[5-(4-carbamimidoylphenoxy)pentyl]oxy}benzene-1-carboximidamide
Traditional IUPAC Name
pentamidine
SMILES
NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1
Độ tan chảy
186.0 °C (decomposes)
pKa (Strongest Basic)
12.13
Refractivity
120.53 m3·mol-1
Dược Lực Học :
Pentamidine is an antiprotozoal agent. It is an aromatic diamidine, and is known to have activity against Pneumocystis carinii. The exact nature of its antiprotozoal action is unknown. in vitro studies with mammalian tissues and the protozoan Crithidia oncopelti indicate that the drug interferes with nuclear metabolism producing inhibition of the synthesis of DNA, RNA, phospholipids and proteins. Little is known about the drug's pharmacokinetics. The medication is also useful in Leishmaniasis and in prophylaxis against sleeping sickness caused by Trypanosoma brucei gambiense. Hydration before treatment lessens the incidence and severity of side effects, which include liver or kidney dysfunction, hypertension, hypotension, hypoglycemia, hypocalemia, leukopenia, thrombcytopenia, anemia, and allergic reaction. It is generally well-tolerated.
Cơ Chế Tác Dụng :
Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of pneumocystis pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects. [PubChem]
The mode of action of pentamidine is not fully understood. It is thought that the drug interferes with nuclear metabolism producing inhibition of the synthesis of DNA, RNA, phospholipids, and proteins.
Dược Động Học :
▧ Absorption :
Absorbed poorly through the gastrointestinal tract and is usually administered parenterally.
▧ Protein binding :
69%
▧ Metabolism :
Hepatic.
▧ Half Life :
9.1-13.2 hours
Độc Tính :
Symptoms of overdose include pain, nausea, anorexia, hypotension, fever, rash, bad taste in mouth, confusion/hallucinations, dizziness, and diarrhea.
Chỉ Định :
For the treatment of pneumonia due to Pneumocystis carinii.
Tương Tác Thuốc :
-
Artemether
Additive QTc-prolongation may occur. Concomitant therapy should be avoided.
-
Lumefantrine
Additive QTc-prolongation may occur. Concomitant therapy should be avoided.
-
Mesoridazine
Increased risk of cardiotoxicity and arrhythmias
-
Quinupristin
This combination presents an increased risk of toxicity
-
Tacrolimus
Additive QTc-prolongation may occur increasing the risk of serious ventricular arrhythmias. Concomitant therapy should be used with caution.
-
Telavancin
Additive QTc-prolongation may occur. Concomitant therapy should be avoided.
-
Thioridazine
Increased risk of cardiotoxicity and arrhythmias
-
Thiothixene
May cause additive QTc-prolonging effects. Increased risk of ventricular arrhythmias. Consider alternate therapy. Thorough risk:benefit assessment is required prior to co-administration.
-
Ticlopidine
Ticlopidine may decrease the metabolism and clearance of Pentamidine. Consider alternate therapy or monitor for adverse/toxic effects of Pentamidine if Ticlopidine is initiated, discontinued or dose changed.
-
Toremifene
Additive QTc-prolongation may occur, increasing the risk of serious ventricular arrhythmias. Consider alternate therapy. A thorough risk:benefit assessment is required prior to co-administration.
-
Trimipramine
Additive QTc-prolongation may occur, increasing the risk of serious ventricular arrhythmias. Concomitant therapy should be used with caution.
-
Voriconazole
Additive QTc prolongation may occur. Consider alternate therapy or monitor for QTc prolongation as this can lead to Torsade de Pointes (TdP).
-
Vorinostat
Additive QTc prolongation may occur. Consider alternate therapy or monitor for QTc prolongation as this can lead to Torsade de Pointes (TdP).
-
Zalcitabine
Additive risk of pancreatitis. Concomitant therapy should be avoided.
-
Ziprasidone
Additive QTc-prolonging effects may increase the risk of severe arrhythmias. Concomitant therapy should be avoided.
-
Zuclopenthixol
Additive QTc prolongation may occur. Consider alternate therapy or use caution and monitor for QTc prolongation as this can lead to Torsade de Pointes (TdP).
Liều Lượng & Cách Dùng :
Powder, for solution - Intravenous
Dữ Kiện Thương Mại
Nhà Sản Xuất
-
Sản phẩm biệt dược : NebuPent
-
Sản phẩm biệt dược : Pentacarinat
-
Sản phẩm biệt dược : Pentacrinat
-
Sản phẩm biệt dược : Pentam
-
Sản phẩm biệt dược : Pentam 300
-
Sản phẩm biệt dược : Pentamidine isethionate
-
Sản phẩm biệt dược : Pneumopent